| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/05/2009 | CN101501006A Pyridinone and pyridazinone derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP) |
| 08/05/2009 | CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators |
| 08/05/2009 | CN101501002A Non-nucleoside reverse transcriptase inhibitors |
| 08/05/2009 | CN101500565A Modulators of muscarinic receptors |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN101500560A Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 08/05/2009 | CN101497614A 1,2,3,5,11,11a- hexahydro-3,3-dimethyl-1-oxo-6H-glyoxaline [3', 4': 1,2] pyridine [3,4-b] diindyl-2-substituted methyl acetate, as well as preparation and application thereof |
| 08/05/2009 | CN101497613A Preparation of praziquanamine |
| 08/05/2009 | CN101497612A Novel carbostyrile compound, preparation and use |
| 08/05/2009 | CN101497611A N-(3-carboxyl-9-benzyl carboline-1-yl) ethyl amino acid, as well as synthesizing method and use thereof |
| 08/05/2009 | CN100523121C 有机电致发光装置和铂化合物 Organic electroluminescent devices and platinum compounds |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/04/2009 | US7569693 Naphthalene-based semiconductor materials and methods of preparing and use thereof |
| 08/04/2009 | US7569688 Propane-1, 3-dione derivative |
| 08/04/2009 | US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals |
| 08/04/2009 | US7569580 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid |
| 08/04/2009 | US7569579 for inhibition of HIV replication and treatment of acquired immune deficiency syndrome |
| 08/04/2009 | US7569578 Heterocyclic anti-migraine agents |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 07/30/2009 | WO2009094668A1 New 2,3,4,5-tetrahydro-1h-pyrido[ 4,3-b] indole compounds and methods of use thereof |
| 07/30/2009 | WO2009094536A1 Fluorogenic hydrazine-substituted compounds |
| 07/30/2009 | WO2009094168A1 Cxcr3 antagonists |
| 07/30/2009 | WO2009094123A1 Protein kinase inhibitors and use thereof |
| 07/30/2009 | WO2009093972A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 07/30/2009 | WO2009093640A1 Amide compound and use thereof |
| 07/30/2009 | WO2009093637A1 Amide compound and use thereof |
| 07/30/2009 | WO2009092565A1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals |
| 07/30/2009 | WO2009092431A1 4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives |
| 07/30/2009 | WO2009067600A3 Biaryl pde4 inhibitors for treating inflammation |
| 07/30/2009 | WO2009055331A3 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 07/30/2009 | WO2009047298A3 Dimers of harmol or of its derivatives and uses thereof |
| 07/30/2009 | WO2009002807A3 Indolyl pyrrolidines for the treatment of cancer |
| 07/30/2009 | WO2008088690A3 A process for preparing diazabicyclo[3.3.1] nonane compounds |
| 07/30/2009 | US20090192312 Brain Function-Improving Agent, and Functional Food Containing the Improving Agent |
| 07/30/2009 | US20090192202 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/30/2009 | US20090192182 Compound having acidic group which may be protected, and use thereof |
| 07/30/2009 | US20090192150 protease-activated receptor 1 (PAR1) inhibitors such as 1-(3,5-di-tert-butyl-4-hydroxyphenyl)-2-(3-iminoimidazo[1,5-a]pyridin-2-yl)ethanone, used as anticoagulants |
| 07/30/2009 | US20090192148 Organic Compounds |
| 07/30/2009 | US20090192147 [a]-FUSED INDOLE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES |
| 07/30/2009 | US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/30/2009 | US20090191177 Enantiomerically Pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-A]pyrimidin-9-yl)ethylamino]benzoic Acid, Its Use In Medical Therapy, And A Pharmaceutical Composition Comprising It - 026 |
| 07/30/2009 | CA2712612A1 4-(pyrrolo[2,3-c]pyridine-3-yl)pyrimidin-2-ylamine derivatives |
| 07/30/2009 | CA2711576A1 Tricyclic compounds as modulators of tnf-.alpha. synthesis and as pde4 inhibitors |
| 07/30/2009 | CA2709806A1 Protein kinase inhibitors and use thereof |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083010A1 Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof |
| 07/29/2009 | EP2083009A1 Substituted tetrahydroimidazopyridine compounds and their use in medicine |
| 07/29/2009 | EP2081931A2 Fused heterocyclic derivatives useful as inhibitors of the hepatocyte growth factor receptor |
| 07/29/2009 | EP2081930A2 Kinase inhibitors |
| 07/29/2009 | EP2081929A1 Substituted 3-isobutyl-9, 10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyridoý2,1-a¨isoquinolin-2-ol compounds and methods relating thereto |
| 07/29/2009 | EP2081928A2 Pyrrolo-pyridine kinase inhibitors |
| 07/29/2009 | EP2081915A2 Bicyclic heteroaromatic compounds |
| 07/29/2009 | EP2081891A2 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 07/29/2009 | EP1885721B1 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 07/29/2009 | EP1786807B1 Heterocyclic antiviral compounds |
| 07/29/2009 | EP1771177A4 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/29/2009 | EP1653955A4 Hydroxylamine substituted imidazo-containing compounds |
| 07/29/2009 | EP1641791B1 3-(guanidinocarbonyl)heterocycle derivatives, preparation process and intermediates of this process, their use as medicaments, and pharmaceutical compositions including them |
| 07/29/2009 | EP1638968B1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1409468B9 Guanidinobenzamides as mc4-r agonists |
| 07/29/2009 | EP1268443B1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/29/2009 | CN101495479A Imidazoazephinone compounds |
| 07/29/2009 | CN101495478A Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 07/29/2009 | CN101495477A Imidazoquinolines as lipid kinase inhibitors |
| 07/29/2009 | CN101492448A 7'-aza indirubin compounds for antineoplastic medicament |
| 07/29/2009 | CN101492447A Carbazole organic semiconductor materials, methods for preparing and using same |
| 07/29/2009 | CN101492446A Novel pyridine-imidazole derivative |
| 07/29/2009 | CN100519534C Method for the production of terylene-3,4:11,12-tetracarboxydiimides by direct synthesis |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/28/2009 | US7566790 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 07/28/2009 | US7566784 Bicyclic heterocycles as kinase inhibitors |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566726 3-Trifluoromethyl,6-((3-(methyl,4-hydroxytetrahydropyran-4-yl)-amino-(3-isopropyl-cyclopent-1,3-ylene))-carbonyl-)-5,6,7,8-tetrahydro-1,6-naphthyridine; antiinflammatory agents; immunomodulators; antiallergens; rhintis; dermatitis; conjunctivits, asthma; autoimmune diseases; antiarthritis agents |
| 07/28/2009 | US7566725 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/28/2009 | CA2462453C Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 07/28/2009 | CA2443012C Use of pyridoindolone derivatives for preparing medicines |
| 07/23/2009 | WO2009091856A2 Beta-lactamase inhibitors |
| 07/23/2009 | WO2009091374A2 Fused heterocyclic derivatives and methods of use as c-met inhibitors |
| 07/23/2009 | WO2009091324A1 Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents |
| 07/23/2009 | WO2009090222A1 Naphthyridin-2(1h) -one compounds useful as antibacterials |
| 07/23/2009 | WO2009090202A1 Monomaleate monohydrate salt of a 5ht1a receptor antagonist |
| 07/23/2009 | WO2009063061A3 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 07/23/2009 | US20090187022 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 07/23/2009 | US20090187021 Indane compounds as ccr5 antagonists |
| 07/23/2009 | US20090186933 Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186902 Substituted Tetrahydroimidazopyridine Compounds and the Use Thereof in the Treatment of Pain and Other Conditions |
| 07/23/2009 | US20090186901 Chemical compounds |
| 07/23/2009 | US20090186889 Spiro-substituted pyrrolopyrimidines |
| 07/23/2009 | US20090186869 Antiviral compounds |
| 07/23/2009 | US20090186200 2,5-di(methoxyanilino) terephthalic acid polymorphs and quinacridones realized therefrom |
| 07/23/2009 | US20090185975 Diagnostic probe for conformation disease |
| 07/23/2009 | DE102008005493A1 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate 4- (pyrrolo [2,3-c] pyridine-3-yl) -pyrimidin-2-yl-amine derivatives |
| 07/23/2009 | CA2712783A1 Beta-lactamase inhibitors |